Minze Health has reached an agreement with Medtronic for three years to market the automated bladder diary solution, Minze ...

Minze Health announced that it entered into a three-year agreement with Medtronic to commercialize its overactive bladder ...

Smile Makers Collection has been on a journey to normalise sexual health through its bright, accessible sex toys for women ...

Chris Eubank Jr's rematch with Conor Benn has brought the controversial issue of how fighters make weight back into focus ...

Detalimogene voraplasmid (detalimogene; formerly EG-70) demonstrated promising responses in patients with high-risk Bacillus ...

An international investigation uncovers how criminal networks traffick parts of the totoaba, an endangered fish caught in ...

And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

Many women experience increased bathroom trips during their periods. This is often normal, linked to hormonal fluctuations ...

Gene Holdings Inc. remains a Buy, driven by promising LEGEND trial data for detalimogene voraplasmid. Learn more about ENGN stock here.

The science around hormone therapy to treat menopause has changed a lot since the FDA issued warning labels 20 years ago. Now ...